Tesnim Dallegi, Syrine Ben Hassen, Nedra Rached, Farah Menjji, Roufaida Abassi, Ameur Cherif, . . . Amor Mosbah. (2024). Design and experimental validation of a new radiolabeled analog of N-(3-hydroxy-4-methoxy-phenyl-methyl) ferrocene-carboxamide (VFC) targeting the TRPV1 receptor. Elsevier.
Chicago Style (17th ed.) CitationTesnim Dallegi, Syrine Ben Hassen, Nedra Rached, Farah Menjji, Roufaida Abassi, Ameur Cherif, Soumaya Kouidhi, Mouldi Saidi, and Amor Mosbah. Design and Experimental Validation of a New Radiolabeled Analog of N-(3-hydroxy-4-methoxy-phenyl-methyl) Ferrocene-carboxamide (VFC) Targeting the TRPV1 Receptor. Elsevier, 2024.
MLA (9th ed.) CitationTesnim Dallegi, et al. Design and Experimental Validation of a New Radiolabeled Analog of N-(3-hydroxy-4-methoxy-phenyl-methyl) Ferrocene-carboxamide (VFC) Targeting the TRPV1 Receptor. Elsevier, 2024.